Curriculum Vitaes
Profile Information
- Affiliation
- Professor, Center for Medical Science, Fujita Health University
- Degree
- M.D.(Mar, 1988, Kyoto University)Ph.D.(Mar, 1992, Kyoto University)
- Researcher number
- 30281091
- J-GLOBAL ID
- 200901025890179259
- researchmap Member ID
- 0000107006
- External link
Our laboratories are involved in development of therapies against intractable diseases including neuromuscular diseases, muscular dystrophies, mood disorders, diabetes/obesity using various cutting-edge technologies.
Research Interests
17Research Areas
9Research History
9-
Jun, 2022 - Present
-
Oct, 2018 - Present
-
2005 - Present
Education
2-
Apr, 1988 - Mar, 1992
-
Apr, 1982 - Mar, 1988
Committee Memberships
11-
Jan, 2020 - Present
-
Feb, 2019 - Present
-
2019 - Present
-
Apr, 2018 - Present
Awards
5Papers
172-
Scientific reports, 15(1) 43802-43802, Dec 15, 2025 Peer-reviewedLast authorCorresponding authorSmall extracellular vesicles (sEVs) mediate cell-to-cell communication by carrying RNAs and proteins. Ubiquitin-like 3 (UBL3) functions as a posttranslational modification factor, regulating protein sorting to sEVs. Programmed cell death ligand 1 (PD-L1) binds to programmed cell death 1 (PD-1) on immune cells, suppressing their function. Although immune checkpoint inhibitors, anti-PD-L1 and anti-PD-1 antibodies, have improved cancer treatment, efficacy remains limited (~ 25%). Per recent studies, PD-L1-containing sEVs are elevated in cancer patients, contributing to impaired immunotherapy responses. Herein, we discovered that PD-L1 is modified by UBL3 and that its sorting to sEVs is regulated by UBL3. Furthermore, we found that statins, commonly prescribed for hypercholesterolemia, inhibit UBL3 modification, thereby reducing PD-L1 sorting to sEVs. Among patients with a high tumor proportion score, serum levels of PD-L1-containing sEVs were significantly lower in those using statins. Consistently, bioinformatic analysis revealed that UBL3 and PD-L1 expression levels affect lung cancer survival. Integrating statins into existing combination therapies may therefore offer a promising strategy to enhance immunotherapy efficacy.
-
Acta neuropathologica communications, Nov 29, 2025 Peer-reviewedLower grade gliomas frequently harbor mutations in isocitrate dehydrogenase (IDH), which define biologically distinct tumor subtypes. Although IDH-mutant and IDH-wildtype gliomas share similar histological morphology, they display markedly different metabolic profiles that may be exploited for targeted therapy. In this study, we investigated therapeutic approaches tailored to these metabolic differences. Using capillary electrophoresis-mass spectrometry, we compared the metabolomes of engineered IDH-wildtype and IDH-mutant glioma cell models. IDH-mutant cells exhibited elevated asparagine levels and reduced glutamine and glutamate levels compared with IDH-wildtype cells. These differences were corroborated in vivo by proton magnetic resonance spectroscopy of 130 patients with diffuse gliomas, showing lower glutamine and glutamate in IDH-mutant tumors. Pharmacological depletion of asparagine with L-asparaginase, which converts asparagine to aspartate, preferentially inhibited the growth of IDH-wildtype glioma cells, and this effect was potentiated by inhibition of asparagine synthetase. In contrast, inhibition of glutamate dehydrogenase 1 (GLUD1), the enzyme catalyzing the conversion of glutamate to α-ketoglutarate, selectively suppressed proliferation of IDH-mutant glioma cells by inducing reactive oxygen species accumulation and apoptosis. In vivo, L-asparaginase suppressed tumor growth in xenografted IDH-wildtype gliomas, whereas GLUD1 inhibition significantly reduced tumor growth in IDH-mutant glioma xenografts. These findings reveal distinct amino acid metabolic vulnerabilities defined by IDH mutation status and identify L-asparaginase and GLUD1 inhibition (via R162) as promising, mutation-specific therapeutic strategies. L-asparaginase demonstrated potent antitumor activity against IDH-wildtype gliomas, while GLUD1 inhibition selectively suppressed IDH-mutant gliomas both in vitro and in vivo. These results highlight the clinical potential of targeting amino acid metabolism in gliomas and provide a strong rationale for translating these mutation-specific approaches into future clinical trials.
-
Oxygen, 5(2) 4-4, Apr 18, 2025 Peer-reviewedBecause soybean is sensitive to salt stress, it is necessary to improve their stress tolerance. Titanium-oxide nanoparticles (TiO2 NPs) enhanced the growth of soybean under salt stress. To elucidate the promotive effects of TiO2 NPs on soybean growth under salt stress, a gel-free/label-free proteomic analysis was carried out. The principal component analysis of proteins showed that TiO2 NPs affected proteins in roots grown under salt stress. The differentially changed proteins were associated with protein metabolism and transport in the biological process, the nucleus in the cellular component, and nucleic acid binding activity in the molecular function. Proteins identified with proteomics were verified using immunoblot analysis. The abundance of V-ATPase decreased in soybean under salt stress and increased with additional TiO2 NPs under stress, whereas xyloglucan endotransglucosylase/hydrolase did not change with any treatment. The abundance of peroxiredoxin increased under salt stress but decreased with additional TiO2 NPs under stress. These results suggest that TiO2 NPs confer salt tolerance in soybean plants at the early growth stage by regulating vacuole transport and reactive oxygen scavenging systems.
-
Cells, 14(7), Apr 3, 2025The role of a simulated microgravity environment on soybean growth was investigated. The root grew more under simulated microgravity conditions than in the presence of gravity. However, root shortening due to salt stress did not occur in simulated microgravity conditions. To reveal these mechanisms by simulated microgravity environment on soybean root, a proteomic analysis was conducted. Proteomic analysis revealed that among 1547 proteins, the abundances of proteins related to phytohormone, oxidative stress, ubiquitin/proteasome system, cell organization, and cell wall organization were altered under stimulated microgravity compared with gravity. Membrane-localized proteins and redox-related proteins were inversely correlated in protein numbers due to salt stress under gravity and the simulated microgravity condition. Proteins identified by proteomics were validated for protein accumulation by immunoblot analysis. Superoxide dismutase and ascorbate peroxidases, which are reactive oxygen species-scavenging proteins, increased in soybean root under salt stress but not in the simulated microgravity conditions even under stress. The accumulation of 45 kDa aquaporin and 70 kDa calnexin in soybean root under salt stress were increased in the simulated microgravity conditions compared to gravity. These findings suggest that soybean growth under salt stress may be regulated through improved water permeability, mitigation of reactive oxygen species production, and restoration of protein folding under simulated microgravity conditions.
-
Journal of Proteome Data and Methods, 7 2, Apr, 2025 Peer-reviewedLast authorCorresponding author
Misc.
192-
Igaku Kyoiku / Medical Education (Japan), 48(5) 323-325, 2017
-
日本生化学会大会・日本分子生物学会年会合同大会講演要旨集, 88回・38回 [4T特-09(3P1185)], Dec, 2015
-
OSTEOARTHRITIS AND CARTILAGE, 22 S130-S131, Apr, 2014
-
筋ジストロフィーおよび関連疾患の診断・治療開発を目指した基盤研究 平成23-25年度 総括研究報告書, 2014
-
Japanese journal of geriatrics, 48(2) 99-103, Mar 25, 2011
-
Japanese journal of geriatrics, 48(2) 99-103, Mar, 2011
Books and Other Publications
16-
The Chemical Biology of Long Noncoding RNAs. RNA Technologies, vol 11. Springer, Cham. ISBN 9783030447427, Oct, 2020
-
Myostatin: Structure, Role in Muscle Development and Health Implications. Nova Science publishers, 2016
Presentations
119-
AOMC-JMS 2024, Sep 13, 2024
-
Joint Conference of the 22nd Annual Meeting of Asian Oceanian Myology Center and the 10th Annual Meeting of Japan Muscle Society (AOMC-JMS 2024), Sep 13, 2024
-
FASEB Science Research Conferences, Biological Methylation: Fundamental Mechanisms, Jul 30, 2024
Teaching Experience
11-
Apr, 2020 - PresentMaster of Medical Science (Fujita Health University)
-
Apr, 2013 - Present
-
Apr, 2010 - PresentPathology (Fujita Health University)
-
Apr, 2008 - PresentMD course Molecular Biology (Fujita Health University)
-
Apr, 2007 - PresentGraduation Research (Fujita Health University)
Professional Memberships
10Works
1Research Projects
29-
科学研究費助成事業, 日本学術振興会, Apr, 2024 - Mar, 2027
-
JADA/スポーツ庁(文部科学省), Jul, 2025 - Feb, 2027
-
科学研究費助成事業, 日本学術振興会, Apr, 2023 - Mar, 2026
-
JADA/スポーツ庁(文部科学省), Jul, 2021 - Feb, 2025
-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2018 - Mar, 2021
Other
3-
① 筋萎縮抑制薬開発。 ② 多種類の筋萎縮誘導モデル、新規二分脊椎モデル。 ③ ヒト正常筋や動物由来の高品質・高純度の筋幹細胞、筋支持細胞の取得技術 その細胞を用いた薬剤探索(筋の脂肪化抑制、骨化抑制)の応用実績。 ④ 乳がん由来細胞を用いた、転移・接着性の分子機構解析(エクソソーム分泌、ホルモン感受性、接着分子制御など)。
-
教育内容・方法の工夫 医学修士学生、医学部生の講義を一部担当。講義内容の理解の助けとし、毎年改訂している。オンライン配信講義・対面講義の両方に工夫をしている。 生成AIを用いた講義資料の作成も心がけている。 医学部の少人数制の生物学の英語テキストの抄読会を行っている。 リサーチマインドを持った医学部学生のSRP(ステューデントリサーチャープログラム)で受け入れと研究指導を行なっている。 医療科学部卒論生の研究指導、発表会に向けた助言を行っている。
教育内容・方法の工夫(授業評価等を含む)
3-
件名(英語)Pathology開始年月日(英語)2010/04/01概要(英語)毎年ファイルを改定し、理解度チェックを入れるなど工夫している。
-
件名(英語)Human Biology開始年月日(英語)2013/04/01概要(英語)医学部2年生の少人数制の英語抄読。医学英語力と発表能力のコンピタンス向上に向け、毎年工夫を凝らしている。2020年度はWeb講義として行っており、それに即した教育法を実践している。
-
件名(英語)Master of Medical Science開始年月日(英語)2020/04/01概要(英語)オンライン講義で、医学部以外の出身者が医学的知識をつけれるように、わかりやすい説明を心がけている。